Immaris – A New Frontier in the Fight Against Cold Water Disease
By: Oreka Solutions
Cold Water Disease (CWD) is one of the major diseases affecting trout and salmon farming. According to the USDA1, CWD can kill up to a third of infected hatchery stock and causes significant economic impact to the $13.7-billion salmonid aquaculture industry. There is no commercial vaccine for CWD and fish veterinarians have a limited repertoire of microbials to manage disease outbreaks.
Oreka Solutions, a Canadian feed additive company, has pioneered the development of anti-microbially optimized supplements derived from black soldier flies for use in animal feed. Its products help improve gut health, leading to improved growth and feed conversion rates.
In the short-term study, fish fed a diet containing Oreka's Immaris product exhibited improved levels of resistance to CWD and mortality reduction. The research was led by Dr Vikas Kumar, at the Fish Nutrition and Nutrigenomics laboratory at the University of Idaho.
"These findings represent an exciting development"
James Alden, CEO of Oreka Solutions added, "While we have validated the performance of Immaris on growth rates and feed conversion in a variety of species, this study is the first to help validate what we have suspected for a while – that it may also have real immunostimulatory properties. It has taken five years of dedicated R&D to develop Immaris and we thank the fabulous team at the University of Idaho, who have partnered with us to demonstrate its potential in helping address CWD."
Oreka is currently expanding its production to serve larger sections of the North American aquaculture and livestock industries while developing partnerships with feed and animal health companies to bring the benefits of Immaris to as many farmers as possible.
Oreka Solutions combines high-nutrient diets, specialized breeding, growing, and processing techniques to deliver a series of feed ingredients, including "Immaris" to improve animal growth rates, feed conversion and reduce mortality.